510(k) device
OviTex PRS (Long-Term Resorbable)
TELA Bio, Inc. · Mesh, Surgical (FTM, Class II) · First FDA decision Mar 21, 2023, newest Dec 19, 2024Breast reconstruction and augmentationHernia
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
2
Naming "OviTex PRS"
MAUDE reports
41
Brand "OviTex PRS", since 2015
PubMed studies
2
Mentioning "OviTex PRS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OviTex PRS (Long-Term Resorbable)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K243595 · Decided Dec 19, 2024 · 29 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
- OviTex PRS510(k)
K241126 · Decided May 22, 2024 · 29 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
K214070 · Decided Mar 21, 2023 · 449 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Wrong Surgical or Other Invasive Procedure Performed on a PatientNational determinationOn the books140.6Updated Nov 5, 2026
- Surgical or Other Invasive Procedure Performed on the Wrong PatientNational determinationOn the books140.8Updated Sep 25, 2026
- Surgical or Other Invasive Procedure Performed on the Wrong Body PartNational determinationOn the books140.7Updated Sep 25, 2026
- Cryosurgical Salvage Therapy for Recurrent Prostate CancerNational analysisReview closedCAG-00064NUpdated Sep 14, 2026
- Electroencephalographic Monitoring During Surgical Procedures Involving the Cerebral VasculatureNational determinationOn the books160.8Updated Jan 23, 2017
- Surgical Treatment of NailsProposed local determinationProposedDL40462Noridian Healthcare Solutions, LLCUpdated Sep 23, 2026
- Minimally-invasive Surgical (MIS) Fusion of the Sacroiliac (SI) JointLocal determinationIn effectL36406Wellpoint FederalUpdated Jul 14, 2026
- Surgical Treatment of Obstructive Sleep Apnea (OSA)Local determinationIn effectL34526WPS Insurance CorporationUpdated Jun 16, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "OviTex PRS", any status and sponsor, newest update first.
Tela Bio IncNot on our public-company list
NCT07135596 · 235 participants (planned) · Start Apr 10, 2026 · Primary completion Jun 2030
Device: OviTex PRS · For: Breast Reconstruction
Sites: Tampa, Florida; Bowling Green, Kentucky; Raleigh, North Carolina
- A Retrospective Assessment of OviTex PRS (OviTex)Active, not recruiting
Tela Bio IncNot on our public-company list
NCT05736848 · 200 participants (planned) · Start Sep 27, 2022 · Primary completion Aug 30, 2026
Device: OviTex® PRS · For: Reconstructive Surgical Procedures
Sites: Naples, Florida; South Miami, Florida; Alpharetta, Georgia · 11 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OviTex PRS", and for the whole product code for context.
This brand
41 reports: 1 malfunction, 40 injury, 0 death
Whole product code FTM
5,291 reports: 219 malfunction, 5,021 injury, 34 death
Newest reports for this brand
- OviTex PRSInjury
MW6002413 · Received Sep 16, 2026 · Event dated May 18, 2026
Device type: Mesh, Surgical (FTM)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Wound Dehiscence; Erythema; Fever; High Blood Pressure/ Hypertension; Unspecified Infection; Necrosis; Pain; Fluid Discharge; Swelling/ Edema
- OviTex PRSInjury
3010513348-2026-00011 · Received Sep 3, 2026 · Event dated Jul 1, 2026
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Erythema
- OviTex PRSInjury
3010513348-2026-00012 · Received Sep 3, 2026 · Event dated Jul 1, 2026
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Erythema
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "OviTex PRS"[tiab]. The summary above synthesizes these.
- In-Vivo Evaluation of a Reinforced Ovine Biologic for Plastic and Reconstructive Procedures in a Non-human Primate Model of Soft Tissue Repair.
Overbeck N, Beierschmitt A, May BC, et al. · Eplasty · 2022
- A Comparison of Ovine-Reinforced Hybrid Mesh (OviTex PRS) With Porcine Acellular Dermal Matrix (STRATTICE) in the Treatment of Advanced Breast Implant Capsular Contracture.
Harfouche CJ, Brucker MJ, Pacella SJ · Aesthet Surg J Open Forum · 2024
Other devices of this type
Also filed under product code FTM.
- Fortaflex Surgical SlingOrganogenesis, Inc. · 510(k) 2002
- CanGaroo Envelope (small)Aziyo Biologics, Inc. · 510(k) 2020
- Gentrix Surgical Matrix, Gentrix Surgical Matrix HiatalAcell, Inc. · 510(k) 2019
- Propatch Soft Tissue Repair MatrixCryolife, Inc. · 510(k) 2012
- Depuy Restore Orthobiologic Soft Tissue ImplantDePuy Orthopaedics, Inc. · 510(k) 2007
- Bioblanket Surgical MeshKensey Nash Corporation · 510(k) 2006
- VersaWrapAlafair Biosciences, Inc. · 510(k) 2021
- Colorado Therapeutics Xenograft ImplantColorado Therapeutics, LLC · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.